SATINDER AGGARWAL: Open Payments
NPI 1700862034 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 83 payments from 23 companies in 2025. Trend: 2023 $1,649 · 2024 $1,744 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $274 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $234 |
| Novo Nordisk Inc | 17 | $218 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Indivior Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
Products named: CAPLYTA, Wegovy, AIRSUPRA, REXULTI, Rybelsus, SUBLOCADE, BREZTRI, Auvelity.
Industry payments across MI — which companies pay providers there.
